When Nikki Myers, 33, found a lump in her neck last fall, she visited an urgent care clinic. She learned she had ovarian ...

Disease-free and overall survival were comparable between paclitaxel- and cisplatin-based heated chemotherapy regimens in ...

Early fallopian tube cell changes were found in a high‑risk patient. A live tissue bank and organoid system will help explore ...

Seward Park is hosting the annual Rivkin Family Run this morning, an event dedicated to raising awareness and funds for ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

A UK-based doctor has shared five symptoms of ovarian cancer, one of the most difficult to detect cancers with a high ...

Researchers identify PPP2R1A gene mutations as a new marker linked to better immunotherapy response and survival in ovarian ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...